Skip to content

Exercise Intolerance in Obstructive Sleep Apnea Syndrome Patients

Exercise Intolerance in Obstructive Sleep Apnea Syndrome Patients: Cardiovascular and Metabolic Characterisation During Exercise. Treatments Effect.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00837018
Acronym
EXAOS
Enrollment
30
Registered
2009-02-04
Start date
2005-06-30
Completion date
2012-05-31
Last updated
2013-03-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obstructive Sleep Apnea

Keywords

OSAS, exercise, metabolic, cardio-vascular

Brief summary

The syndrome of obstructive sleep apnea (OSAS) is a public health problem that affects 2 to 4% of the general population. The patients with OSAS frequently complain of intolerance to exercise muscle fatigue and a significant even if they have not been fully characterized in the literature. The anomalies in the exercise of patients with OSAS could be due to metabolic changes (insulin resistance and oxidative stress) and cardiovascular (impaired vascular reactivity). Our goal is both to determine whether these anomalies exist in patients with OSAS not obese, consider their relationship with the alteration of exercise capacity, and their reversibility in conventional PPC or by using the effects of physical activity regular.In this study Objectives: To establish whether the metabolic and vascular abnormalities associated with OSAS are associated with decreased parameters of physical fitness in relation to witnesses matched for age, sex and body mass index. Determine the effects of a re-training exercise on these parameters compared to the reference treatment, continuous positive pressure. Main objective: To compare the exercise capacity of OSAS patients compared with that of witnesses matched for age, sex and body mass index. Secondary objectives: To compare the effect of conventional treatment by continuous positive pressure (CPP) on cardiovascular and metabolic abnormalities of OSAS, with a therapeutic modality most original, physical activity. Methodology: Test physiopathological parallel group, controlled, randomized.

Detailed description

Study type : Physiopathology trial Study design : Prospective randomized controled trial Expected Total Enrollment : 45 patients + 15 control subjects Tested treatment : Physical exercise program (45 minutes, 3 times a week) Reference treatment : continuous positive airway pressure Treatment duration : 12 weeks (3 months) Total study duration : 2 years

Interventions

45 min, 3times a week

Sponsors

AGIR à Dom
CollaboratorOTHER
University Hospital, Grenoble
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
FACTORIAL
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
40 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Ages Eligible for Study : 18 Years and above * Genders Eligible for Study: Both * Non obese : body mass index (BMI \< 30 kg/m2) * Sedentary subjects : less physical activity than 30 minutes 3 time a week * and VOORIPS physical activity level questionnaire score \< 9. Obstructive sleep apnea syndrome (OSAS) patients : * Recently diagnosed (\< 3 months) * AHI \> 30 / hour (polysomnographic monitoring measurement)

Exclusion criteria

* Excessive daytime sleepiness (Epworth score \> 12) * Cardiovascular pathology (except controlled hypertension) * Pathology interacting with physical activity * Diabetes (known or treated) * Other participation to a clinical trial at the same

Design outcomes

Primary

MeasureTime frame
Comparison of maximal oxygen consumption : OSAS patient versus control subjects.when the last patient realised the last visit

Secondary

MeasureTime frame
To compare physical exercise program to continuous positive airway pressure after 12 weeks of treatment in OSAS patients.when the last patient realised the last visit

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026